Pakistan eye changes for Lord’s Test after heavy defeat

Millions of people rely on weight-loss injections like Ozempic, Wegovy, and Mounjaro to shed extra pounds. Now, new research suggests these drugs may come with an unexpected downside. A recent study found that these medications significantly raise the risk of hair loss. Patients using them were found to be 70 percent more likely to experience hair loss compared to those on other diabetes medications. The research came from a team at the University of Pennsylvania. They reviewed more than 50,000 health records for the study and their findings showed a clear link between Wegovy, Mounjaro, and a higher chance of developing alopecia. Since these drugs are also prescribed for type 2 diabetes, researchers compared them against other diabetes treatments. These included SGLT-2 inhibitors and DPP-4 inhibitors. The results were striking. People taking GLP-1 drugs were 69 percent more likely to experience hair loss than those on DPP-4 inhibitors. They were also 37 percent more likely to face hair loss compared to SGLT-2 inhibitor users. Researchers noted that hair loss tended to appear around the one-year mark after starting treatment. The pattern showed up in both men and women, though it seemed more pronounced in women. The study’s authors explained that hormonal shifts triggered by the drugs could affect hair growth. This effect may be stronger in people who already have underlying hormonal conditions. They said their findings build on earlier informal reports and offer clearer evidence for doctors to consider. Importantly, the hair loss identified was non-scarring. This means the hair follicles remain intact, leaving room for regrowth over time. The FDA has reportedly been collecting reports of hair loss linked to these medications. The agency is said to be reviewing the issue as a possible safety concern. Experts pointed to several possible explanations. Strict calorie cutting can create psychological stress and lead to shortages of key nutrients like iron, zinc, and biotin. These deficiencies can interfere with normal hair growth cycles. Hormonal changes caused by the drugs themselves were also flagged as a contributing factor. A weight-management researcher from the University of Cambridge added some context. They noted the increased risk translates to roughly three extra recorded hair loss cases per 1,000 person-years of treatment, compared to other diabetes drugs.

Prince Harry is once again facing sharp criticism from royal commentators. The backlash follows his defeat in a High Court privacy case against Associated Newspapers on July 7. Royal broadcaster Neil Sean weighed in on the mounting pressure surrounding the Duke of Sussex. He suggested much of the current turmoil is self-inflicted, pointing out that Harry has effectively made his struggles public for the world to see. Sean went further, describing Harry as someone visibly on edge right now. He questioned whether the prince’s current mindset appeared healthy given everything unfolding around him. According to Sean, the court defeat has left Harry navigating a genuinely difficult situation largely on his own. He suggested the fallout from the case has affected Harry far more deeply than he’d likely admit publicly. Sean noted that this marks unfamiliar territory for Harry, who has typically had support systems, like a private secretary, to help manage this kind of crisis. He said the experience of realising not everything he touches turns out successfully has clearly been difficult for him to process. Beyond the reputational damage, financial concerns are also mounting. Commentator Mark Dolan did not hold back, describing the situation as a full-blown financial disaster for the prince. Dolan estimated Harry could be facing costs anywhere between $10 million and $20 million as a result of the case. He said even a conservative estimate of $10 million would essentially wipe out all the money Harry earned from his memoir, “Spare.” Dolan raised pointed questions about whether Harry actually has the funds to cover those costs. He also wondered how Meghan Markle might be reacting to the situation, and what Harry’s next move could realistically look like. According to Dolan, the scale of the financial fallout makes this a defining moment for Harry, describing it as an existential crisis for the prince. With both reputational and financial pressures mounting simultaneously, commentators suggest this latest setback could prove especially difficult for Harry to recover from.